Taiho Innovations

Taiho Innovations, established in 2019, is the corporate venture capital arm of Taiho Pharmaceutical, located in Tokyo, Japan. The company specializes in investing in seed-stage and early-stage startups within the biotechnology and consumer healthcare sectors. Taiho Innovations aims to support innovative companies that are developing technologies and solutions to enhance health and well-being in Japan. By focusing on these strategic areas, Taiho Innovations seeks to foster growth and innovation in the healthcare landscape.

Fumitaka Mori

Partner

1 past transactions

Enu Pharma

Seed Round in 2024
Enu Pharma is a pharmaceutical company focused on innovative research and the development of advanced medicines aimed at improving global healthcare standards. The company has developed a proprietary nanosome technology designed to assist healthcare professionals in effectively treating challenging diseases. This technology features core metals enveloped in an antiadhesive mixed self-assembled monolayer, which helps prevent non-specific surface protein interactions. By enhancing drug discovery, development, and delivery, Enu Pharma seeks to unlock new therapeutic possibilities and address unmet medical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.